Hematologist
CION Cancer Clinics
Inhibitors in haemophilia: why factor stops working | CION Cancer Clinics
An inhibitor is an antibody your immune system makes against the factor used to treat haemophilia, so bleeds stop responding the usual way. Up to about 1 in 3 people with severe haemophilia A develop one, mostly as young children. A blood test confirms it. Bypassing medicines, emicizumab and immune tolerance treatment can still control bleeding. This page explains the signs, the report and what to ask. At CION Cancer Clinics, our haematologist cares for anaemia, bleeding, clotting and inherited blood disorders, with ArogyaSri, CGHS and cashless insurance accepted.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What is an inhibitor in haemophilia?
- Who is more likely to develop an inhibitor?
- How is an inhibitor found?
- What do the words on the inhibitor report mean?
- How are inhibitors treated?
- What do families get wrong about inhibitors?
- What can this page not tell you, and what should you ask?
- Common questions about haemophilia inhibitors
The short answer
What is an inhibitor in haemophilia?
An inhibitor is an antibody that your immune system makes against the factor you are given for haemophilia. It treats the factor as something foreign and switches it off, so the injection stops controlling bleeds the way it used to.
Why the body does this
In severe haemophilia, the body has made little or no factor of its own since birth. When factor is first given, the immune system may not recognise it as part of the body. In some people it responds as it would to a germ, and builds antibodies against it. Nobody did anything wrong for this to happen. It is not caused by a missed injection or a poor diet.
What changes for you
Bleeds that used to settle after one injection may carry on, or come back quickly. A joint may keep swelling despite treatment. Regular preventive factor may stop working. Your plan does not end here. It changes, and there are other medicines built for this situation.
Who this page is not for
If you or your child is bleeding right now and the usual factor is not working, do not read on. Go to the nearest emergency department or call 108, and tell them the person has haemophilia.
Inhibitors are much more common in haemophilia A than in haemophilia B, but they can happen in both.Risk
Who is more likely to develop an inhibitor?
Some things raise the chance. None of them decides it. Many children with every risk factor never develop one.
How severe the haemophilia is
People with severe haemophilia A carry the highest chance. Up to about 1 in 3 of them develop an inhibitor at some point. In mild and moderate haemophilia it is much less common.
The early treatment years
Most inhibitors appear in young children, during the first stretch of treatments with factor. After a child has had factor many times without one, a new inhibitor becomes much less likely.
The gene change and family history
Some kinds of change in the factor gene carry more risk than others. A brother or cousin with an inhibitor also raises the chance.
Tell your team if
- A relative with haemophilia had an inhibitor
- You have an old genetic test report
Intense treatment at one time
A large amount of factor in a short period, such as after surgery or a serious bleed, has been linked to a higher chance in some studies. The evidence is not settled, so your team weighs it case by case.
Not sure whether this applies to you?
Ask an oncologistFinding it
How is an inhibitor found?
A sign that something has changed
The first clue is usually practical. A bleed does not settle after the usual treatment, or bleeds become more frequent on the same preventive plan. Write down the date, the bleed and what was given.
A blood sample
Your haematologist asks for an inhibitor screen on a blood sample. Some centres also check routinely during the early treatment years, before any problem shows.
The Bethesda test
If the screen is positive, the laboratory measures how strong the inhibitor is. The result is reported in Bethesda units. A higher number means a stronger inhibitor.
A repeat test
One result is rarely acted on alone. The test is usually repeated to confirm it, because some inhibitors are weak and fade on their own, and laboratories differ in how they run it.
On your report
What do the words on the inhibitor report mean?
- Inhibitor screen
- A first test that says whether an inhibitor is likely present. It does not say how strong it is.
- Bethesda units (BU)
- The measure of inhibitor strength. It is compared between tests over time, so keep every report.
- Low-responding inhibitor
- An inhibitor that stays weak even after more factor is given. Some people can still be treated with higher amounts of their usual factor.
- High-responding inhibitor
- An inhibitor that rises sharply after factor is given. The usual factor stops working, and a different kind of treatment is needed.
- Factor VIII or IX level
- How much clotting factor is in the blood. Reference ranges differ between laboratories.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Treatment
How are inhibitors treated?
Treatment has two jobs. The first is to stop and prevent bleeds while the inhibitor is present. The second, for some people, is to try to make the inhibitor go away.
Bypassing agents for bleeds
These medicines help blood clot by a route that does not need factor VIII or IX, so the inhibitor cannot block them. The two in common use are recombinant factor VIIa and activated prothrombin complex concentrate. They are given into a vein, often more than once for a single bleed. Your team decides which one, and how much.
Emicizumab for prevention in haemophilia A
Emicizumab is an injection under the skin that does part of factor VIII's job. The inhibitor does not switch it off. For many people with haemophilia A and an inhibitor it has made regular prevention far easier. It does not treat a bleed that has already started, and it does not suit haemophilia B.
Immune tolerance induction (ITI)
ITI means giving factor regularly, often for a long time, to teach the immune system to accept it. It works for many people but not all. It needs frequent injections into a vein and close follow-up, which is hard for some families to keep up. It is less likely to suit people whose inhibitor has been present for a long time.
Do not change or stop any factor, bypassing agent or emicizumab on your own. Mixing some of these without guidance can cause clots.Commonly believed
What do families get wrong about inhibitors?
"We gave too much factor, so we caused the inhibitor."
An inhibitor comes mainly from how your immune system and genes respond. Parents who followed the plan did not cause it. Guilt helps nobody, and the next step is the same whatever the cause.
"If factor has stopped working, we should stop treatment."
Stopping treatment leaves bleeds uncontrolled, and repeated joint bleeds cause lasting damage. There are other medicines for exactly this situation. Speak to your haematologist before changing anything.
"An inhibitor means haemophilia has become a blood cancer."
It does not. An inhibitor is an immune reaction to factor. Haemophilia is not a cancer and does not turn into one because an inhibitor appears.
"Once an inhibitor appears, it is there for life."
Some weak inhibitors fade on their own. Others go away with immune tolerance treatment. Some stay, and are then managed with bypassing agents or emicizumab. Your haematologist can tell you which picture fits your own results.
Being straight with you
What can this page not tell you, and what should you ask?
This page cannot tell you whether your child will develop an inhibitor, how strong one will be, or whether it will go away. Those answers come from repeat blood tests, the history of bleeds and a haematologist who knows the whole picture.
Questions worth taking to the appointment
Ask how strong the inhibitor is, and whether it is low-responding or high-responding. Ask which medicine to use for a bleed at home, and which to avoid. Ask whether emicizumab or immune tolerance treatment suits your situation, and why or why not. Ask what the emergency department should be told, and get it in writing.
Where CION fits
CION's haematology team reviews the reports, discusses the case at a tumour board and coordinates care with a haemophilia treatment centre where specialised testing or supply is needed.
Scheme rules on free factor, bypassing agents and emicizumab change. Check the current rules with your state haemophilia centre.Questions we are asked
Common questions about haemophilia inhibitors
How would I know my child has developed an inhibitor?
The usual sign is that factor stops working as well as it did. A bleed may not settle, a joint may keep swelling, or bleeds may come more often on the same plan. Only a blood test can confirm it. Tell your haematologist early rather than waiting to see if it passes.
Can adults develop an inhibitor too?
Yes, though it is much less common than in young children. It can happen after surgery, a serious bleed that needed a lot of factor, or a change of factor product. Adults with mild haemophilia can also develop one. If treatment suddenly works less well, ask for a test whatever your age.
Does switching factor brand cause inhibitors?
Studies have looked at this and the answers are not fully settled. Most people switch products without any problem. Because switching is often decided by supply or a scheme, ask your team whether an inhibitor test is worth doing after a change, especially for a young child.
Can an inhibitor go away?
Sometimes. Weak inhibitors may fade on their own. Others can be removed with immune tolerance treatment, which works for many people but not everyone. Some inhibitors stay. Your haematologist reads your repeat Bethesda results over time to tell which of these you are facing.
Is emicizumab available for inhibitor patients in India?
It is approved in India, but access depends on cost, supply and whether your state programme offers it. Some families reach it through a scheme or a haemophilia treatment centre. Ask your haematologist whether it suits you, and check the current scheme rules before assuming.
What should the emergency department be told?
Say the person has haemophilia A or B with an inhibitor, and show the latest report. Name every medicine used for bleeds, and whether they take emicizumab. This matters because some combinations can cause clots, and some blood tests read wrongly on emicizumab. Carry a written card.
Can my child still go to school and play?
Usually yes, with a plan. Children with inhibitors may need more care around rough contact sports. Share the bleed plan with the school, and make sure a teacher knows who to call. Your team can help you choose activities that keep joints strong without taking unneeded risks.
Will an inhibitor affect planning for surgery or dental work?
Yes. Any planned procedure needs your haematologist involved well beforehand, because the usual factor may not protect you. The team plans which bypassing agent or other medicine will cover the procedure. Never book dental extraction or surgery without telling them first.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NHS — Haemophilia
- National Heart, Lung, and Blood Institute — Hemophilia
- American Society of Hematology — Hemophilia
- National Health Mission, India — National Health Mission
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Factor Replacement Therapy ExplainedHow factor works before an inhibitor changes thingsEmicizumab and Newer OptionsThe preventive injection that inhibitors do not blockSeverity in Haemophilia: Mild, Moderate, SevereWhy severity changes the inhibitor riskSurgery and Dental Work With a Bleeding DisorderPlanning procedures when factor may not protect youBleeding Disorders and HaemophiliaThe full guide to bleeding disorders
Talk to us
Worried that factor is not working as it did?
Tell us what the recent bleeds and reports show. CION's haematology team will review them with you and help you reach the right care.